Showing results (161-170 of 442) with videos related to

Sort By:
Pageof 45
Journal of Crohn'S & Colitis|February 13, 2019
Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease StudiesRemo Panaccione, Robert Löfberg, Paul Rutgeerts, et al.
The Lancet. Gastroenterology & Hepatology|November 8, 2019
Improving the quality of surveillance colonoscopy in inflammatory bowel diseaseMarietta Iacucci, Rosanna Cannatelli, Gian Eugenio Tontini, et al.
Canadian Journal of Gastroenterology & Hepatology|March 25, 2015
Living with inflammatory bowel disease: A Crohn's and Colitis Canada surveyHelen M Becker, Daniel Grigat, Subrata Ghosh, et al.
Frontiers in Pediatrics|August 16, 2021
Early Serum Infliximab Levels in Pediatric Ulcerative ColitisJennifer C C deBruyn, Kevan Jacobson, Wael El-Matary, et al.
Plos One|January 17, 2020
Patient preferences for maintenance therapy in Crohn's disease: A discrete-choice experimentGlen S Hazlewood, Gyanendra Pokharel, Robert Deardon, et al.
Inflammatory Bowel Diseases|July 27, 2023
Despite Increased Disease Activity, Women who Attended a Dedicated Inflammatory Bowel Disease and Pregnancy Clinic Had Infants With Higher Apgar Scores: A Population-Based StudySangmin Lee, Cynthia H Seow, Kara Nerenberg, et al.
The American Journal of Gastroenterology|July 12, 2023
Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future DirectionsMarla Dubinsky, Alison Potts Bleakman, Remo Panaccione, et al.
Inflammatory Bowel Diseases|February 13, 2019
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID RegistryEdward V Loftus, Walter Reinisch, Remo Panaccione, et al.
Gastroenterology|March 10, 2015
Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensusBrian Bressler, John K Marshall, Charles N Bernstein, et al.
Crohn'S & Colitis 360|July 1, 2025
Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative ColitisRemo Panaccione, Faye Chan-Diehl, Simin Baygani, et al.
Pageof 45